27 related articles for article (PubMed ID: 38560899)
1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
[TBL] [Abstract][Full Text] [Related]
2. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
3. Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?
Kariya H; Buist DSM; Anderson ML; Lin J; Gao H; Ko LK; Winer RL
Prev Med; 2022 Jan; 154():106896. PubMed ID: 34800474
[TBL] [Abstract][Full Text] [Related]
4. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study.
Ruel-Laliberté J; Jacob-Wagner M; Bestman-Smith J; Paré J
J Obstet Gynaecol Can; 2023 Apr; 45(4):261-266. PubMed ID: 36870436
[TBL] [Abstract][Full Text] [Related]
6. For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
Batur P
Ann Intern Med; 2024 Apr; 177(4):JC46. PubMed ID: 38560899
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
Madzima TR; Vahabi M; Lofters A
Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance in human papillomavirus testing for primary cervical screening.
Cuschieri K; Fellner MD; Arroyo Mühr LS; Padalko E; Correa RM; Dillner J; Gultekin M; Picconi MA
Int J Gynecol Cancer; 2023 May; 33(5):802-811. PubMed ID: 36914171
[TBL] [Abstract][Full Text] [Related]
9. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
Whitlock EP; Vesco KK; Eder M; Lin JS; Senger CA; Burda BU
Ann Intern Med; 2011 Nov; 155(10):687-97, W214-5. PubMed ID: 22006930
[TBL] [Abstract][Full Text] [Related]
10. VALGENT: A protocol for clinical validation of human papillomavirus assays.
Arbyn M; Depuydt C; Benoy I; Bogers J; Cuschieri K; Schmitt M; Pawlita M; Geraets D; Heard I; Gheit T; Tommasino M; Poljak M; Bonde J; Quint W
J Clin Virol; 2016 Mar; 76 Suppl 1():S14-S21. PubMed ID: 26522865
[TBL] [Abstract][Full Text] [Related]
11. Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.
Rebolj M; Sargent A; Njor SH; Cuschieri K
Int J Cancer; 2023 Jul; 153(1):8-19. PubMed ID: 36385698
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
